Announcements

The Kraft Heinz Company filed a Form 8-K with the SEC on August 26, 2026, disclosing a voluntary transfer of its common stock listing from The Nasdaq Global Select Market to the New York Stock Exchange, with trading on the NYSE expected to begin …

CPI Card Group Inc. filed a Form 8-K with the SEC on August 26, 2026, disclosing the appointment of Brennan Hughes as Chief Accounting Officer effective August 24, 2026, and the departure of Donna Abbey Carmignani from that role effective August 20, 2026.

Celcuity Inc. filed a Form 8-K on August 26, 2026, disclosing that it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for REVTORPYK (gedatolisib) for the treatment of certain patients with advanced or metastatic breast cancer.

Somnigroup International Inc. filed a Form 8-K with the SEC on August 26, 2026, reporting the completion of its acquisition of Leggett & Platt, Incorporated through an all-stock merger in which Leggett & Platt became a direct, wholly owned subsidiary of the company.

Duos Technologies Group, Inc. filed a Form 8-K on August 26, 2026, reporting the appointment of Christopher J. DeAlmeida as Chief Financial Officer, effective August 24, 2026, and the return of interim CFO Adrian Goldfarb to his prior advisory role.

Summit Therapeutics Inc. filed a Form 8-K with the SEC on August 26, 2026, reporting that partner Akeso, Inc. announced positive topline results from the Phase III HARMONi-GI1 study evaluating ivonescimab plus chemotherapy as a first-line treatment for advanced biliary tract cancer.

Gevo, Inc. filed a Form 8-K with the SEC on August 26, 2026, disclosing the appointment of Greg Hanselman as Chief Operating Officer, effective August 20, 2026.